Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026)
Insight Molecular Diagnostics (IMDX) EPS (Basic) Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -142.65% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 11.28% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 9.02% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 17.45% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 60.00% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 14.79% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -20.00% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 6.02% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 6.51% |
| 10 | Insight Molecular Diagnostics | 4.34 Mn | -24.59 Mn | 15,000.00 | 53.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.85% |
| Dec 31, 2025 | 67.83% |
| Sep 30, 2025 | 65.31% |
| Jun 30, 2025 | 16.67% |
| Mar 31, 2025 | 76.99% |
| Dec 31, 2024 | -32.62% |
| Sep 30, 2024 | -24.05% |
| Jun 30, 2024 | 66.36% |
| Mar 31, 2024 | -237.80% |
| Dec 31, 2023 | -138.03% |
| Sep 30, 2023 | 51.23% |
| Jun 30, 2023 | -345.83% |
| Mar 31, 2023 | 2,150.00% |
| Dec 31, 2022 | 2,782.35% |
| Sep 30, 2022 | -980.00% |
| Jun 30, 2022 | -100.00% |
| Mar 31, 2022 | 20.00% |
| Dec 31, 2021 | -70.00% |
| Sep 30, 2021 | -50.00% |
| Jun 30, 2021 | -185.71% |